China Yan Tan, CEO of Xbiome, the first AI-based microbiome drug development company in China, outlines the rationale behind the firm’s founding, what makes its technology platform unique, and the challenges of attaining funding for cutting-edge innovation. Despite being a relatively new company, in 2019, we raised the most money…
See our Cookie Privacy Policy Here